AEMD Stock Overview
A medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Aethlon Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.40 |
| 52 Week High | US$2.35 |
| 52 Week Low | US$0.24 |
| Beta | 1.75 |
| 11 Month Change | 7.81% |
| 3 Month Change | -21.25% |
| 1 Year Change | -76.01% |
| 33 Year Change | -98.46% |
| 5 Year Change | -98.61% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
Aug 02
FDA approves protocol change in Aethlon's trial of its purifier to treat severe COVID
Jul 11We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
Mar 18We're Interested To See How Aethlon Medical (NASDAQ:AEMD) Uses Its Cash Hoard To Grow
Nov 09Aethlon Medical climbs on Reddit interest
Jun 09We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
May 12We're Hopeful That Aethlon Medical (NASDAQ:AEMD) Will Use Its Cash Wisely
Jan 27Aethlon Medical has a new business and medical chief
Jan 06Aethlon Medical (AEMD) rockets 63% as FDA amends Hemopurifier IDE for COVID-10 treatment
Dec 16Aethlon names Charles J. Fisher, Jr., M.D. as CEO
Nov 03Shareholder Returns
| AEMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.3% | 1.5% | 2.2% |
| 1Y | -76.0% | 20.8% | 31.6% |
Return vs Industry: AEMD underperformed the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: AEMD underperformed the US Market which returned 31.7% over the past year.
Price Volatility
| AEMD volatility | |
|---|---|
| AEMD Average Weekly Movement | 11.9% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AEMD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: AEMD's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 14 | Jim Frakes | www.aethlonmedical.com |
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
Aethlon Medical, Inc. Fundamentals Summary
| AEMD fundamental statistics | |
|---|---|
| Market cap | US$5.63m |
| Earnings (TTM) | -US$11.27m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.5x
P/E RatioIs AEMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AEMD income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$11.27m |
| Earnings | -US$11.27m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.81 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did AEMD perform over the long term?
See historical performance and comparison